Ignite Creation Date:
2024-05-06 @ 9:52 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03096847
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2017-03-10
Brief Title:
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Pagets disease | View |
| ribociclib | View |
| LEE011 | View |
| RIBECCA | View |
| breast cancer | View |
| breast carcinoma | View |
| HR-positive | View |
| HER2-negative | View |
| advanced breast cancer | View |
| Letrozole | View |
| CDK46 | View |
| breast lump | View |
| HER2 positive | View |
| metastatic breast cancer | View |
| breast cancer positive for human epidermal growth factor receptor 2 HER2 HER2 positive metastatic breast cancer | View |
| breast cancer progression | View |
| estrogen-receptor ER positive breast cancer | View |